Showing 1231-1240 of 18571 results for "".
Advances in Pediatric Eczema Care: Emerging Biologics, JAK Inhibitors, and Beyond
https://reachmd.com/programs/dermconsult/advances-in-pediatric-eczema-care-emerging-biologics-jak-inhibitors-and-beyond/35500/Between four FDA-approved biologics, two oral JAK inhibitors, and an exciting pipeline that features novel therapies and extended dosing innovations, the treatment of pediatric eczema is rapidly evolving. Catch up on the latest updates and where the landscape is headed with Dr. Peter Lio, Clinical AImproving Surgical Outcomes: Strategies to Prevent Wound Complications
https://reachmd.com/programs/clinicians-roundtable/improving-surgical-outcomes-strategies-to-prevent-wound-complications/35838/Postsurgical wound complications can drastically impact patient outcomes, lead to preventable readmissions, and drive up healthcare costs. Hear from Dr. Karen Bauer as she explores the multifactorial risks that increase susceptibility to wound dehiscence and infection and provides proactive strategiInvestigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
https://reachmd.com/programs/project-oncology/investigating-at-home-subcutaneous-atezolizumab-for-nsclc-an-ongoing-study/35769/Can the immune checkpoint inhibitor atezolizumab be safely administered subcutaneously at home for patients with non-small cell lung cancer (NSCLC)? That’s the exact question an ongoing study is seeking to answer, and here to discuss the study’s objective, design, and potential implications for homeAdvancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
https://reachmd.com/programs/frontlines-cidp/advancing-cidp-research-targeted-therapies-ai-integration-and-immunological-insights/33069/From innovative diagnostic strategies to targeted immunotherapies, our approach to chronic inflammatory demyelinating polyneuropathy (CIDP) management is rapidly evolving. Dr. Karissa Gable, Assistant Professor of Neurology at Duke University Medical Center, breaks down the new developments that aimFuture Directions in Psoriasis Treatment: Innovations and Implications
https://reachmd.com/programs/frontlines-psoriasis/future-directions-in-psoriasis-treatment-innovations-and-implications/32439/Dr. Andrew Blauvelt shares his insights on the evolving treatment landscape for psoriasis, from novel oral therapies to biologic injections.Acute Ischemic Stroke in the Third Trimester of Pregnancy: A Case of Successful Treatment with Tenecteplase and Thrombectomy
https://practicalneurology.com/diseases-diagnoses/stroke/acute-ischemic-stroke-in-the-third-trimester-of-pregnancy-a-case-of-successful-treatment-with-tenecteplase-and-thrombectomy/35560/The authors present a case of ischemic stroke in an individual in the third trimester of pregnancy, with favorable outcomes for both the mother and infant resulting from treatment with both tenecteplase and thrombectomy.Lessons from COVID: The Ripple Effect on Immunity
https://reachmd.com/programs/what-your-patients-are-talking-about/lessons-from-covid-the-ripple-effect-on-immunity/15489/Here’s how lifesaving measures used during the COVID-19 pandemic affected the immune system’s ability to fend off other illnesses.Assessing the Effectiveness of Intravenous Ertapenem in HS Patients
https://reachmd.com/programs/dermconsult/assessing-the-effectiveness-of-intravenous-ertapenem-in-hs-patients/18110/Read more to explore the optimal course duration, efficacy, and patient satisfaction associated with intravenous ertapenem for HS.Improving Outcomes for Patients with PCOS
https://reachmd.com/programs/advances-in-womens-health/improving-outcomes-for-patients-with-pcos/16171/How can we improve outcomes for our patients with PCOS? Tune in.Identifying and Approaching Patients and Colleagues of Domestic Violence
https://reachmd.com/programs/advances-in-womens-health/identifying-and-approaching-patients-and-colleagues-of-domestic-violence/16170/Healthcare providers are three times more likely to be involved in domestic violence situations. Here’s how we can identify and help them.